These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


280 related items for PubMed ID: 15791506

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The conundrum of fluoroquinolone prophylaxis.
    Freifeld A, Sepkowitz K.
    Nat Clin Pract Oncol; 2006 Oct; 3(10):524-5. PubMed ID: 17019427
    [No Abstract] [Full Text] [Related]

  • 5. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Almyroudis NG, Segal BH.
    N Engl J Med; 2006 Jan 05; 354(1):90-4; author reply 90-4. PubMed ID: 16395832
    [No Abstract] [Full Text] [Related]

  • 6. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
    Slavin MA, Lingaratnam S, Mileshkin L, Booth DL, Cain MJ, Ritchie DS, Wei A, Thursky KA, Australian Consensus Guidelines 2011 Steering Committee.
    Intern Med J; 2011 Jan 05; 41(1b):102-9. PubMed ID: 21272174
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Pasqualotto AC, Rosa DD, Machado AL.
    N Engl J Med; 2006 Jan 05; 354(1):90-4; author reply 90-4. PubMed ID: 16395830
    [No Abstract] [Full Text] [Related]

  • 10. Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.
    Reuter S, Kern WV, Sigge A, Döhner H, Marre R, Kern P, von Baum H.
    Clin Infect Dis; 2005 Apr 15; 40(8):1087-93. PubMed ID: 15791505
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial prophylaxis in patients with cancer and neutropenia.
    Eller P, Pechlaner C.
    N Engl J Med; 2006 Jan 05; 354(1):90-4; author reply 90-4. PubMed ID: 16395828
    [No Abstract] [Full Text] [Related]

  • 12. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
    Lo N, Cullen M.
    Hematol Oncol; 2006 Sep 05; 24(3):120-5. PubMed ID: 16783844
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.